199 related articles for article (PubMed ID: 37341301)
1. ANO1-Mediated Inhibition of Cancer Ferroptosis Confers Immunotherapeutic Resistance through Recruiting Cancer-Associated Fibroblasts.
Jiang F; Jia K; Chen Y; Ji C; Chong X; Li Z; Zhao F; Bai Y; Ge S; Gao J; Zhang X; Li J; Shen L; Zhang C
Adv Sci (Weinh); 2023 Aug; 10(24):e2300881. PubMed ID: 37341301
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Ca
Liu Z; Zhang S; Hou F; Zhang C; Gao J; Wang K
Int J Cancer; 2019 May; 144(9):2215-2226. PubMed ID: 30243029
[TBL] [Abstract][Full Text] [Related]
3. The Mechanistic Role of the Calcium-Activated Chloride Channel ANO1 in Tumor Growth and Signaling.
Bill A; Alex Gaither L
Adv Exp Med Biol; 2017; 966():1-14. PubMed ID: 28293832
[TBL] [Abstract][Full Text] [Related]
4. Role of ANO1 in tumors and tumor immunity.
Li H; Yu Z; Wang H; Wang N; Sun X; Yang S; Hua X; Liu Z
J Cancer Res Clin Oncol; 2022 Aug; 148(8):2045-2068. PubMed ID: 35471604
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells.
Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW
Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553
[TBL] [Abstract][Full Text] [Related]
6. High ANO1 expression is a prognostic factor and correlated with an immunosuppressive tumor microenvironment in pancreatic cancer.
Zhang G; Shu Z; Yu J; Li J; Yi P; Wu B; Deng D; Yan S; Li Y; Ren D; Hou Y; Lan C
Front Immunol; 2024; 15():1341209. PubMed ID: 38352864
[TBL] [Abstract][Full Text] [Related]
7. Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling.
Britschgi A; Bill A; Brinkhaus H; Rothwell C; Clay I; Duss S; Rebhan M; Raman P; Guy CT; Wetzel K; George E; Popa MO; Lilley S; Choudhury H; Gosling M; Wang L; Fitzgerald S; Borawski J; Baffoe J; Labow M; Gaither LA; Bentires-Alj M
Proc Natl Acad Sci U S A; 2013 Mar; 110(11):E1026-34. PubMed ID: 23431153
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of calcium-activated chloride channel ANO1 suppresses proliferation and induces apoptosis of epithelium originated cancer cells.
Guan L; Song Y; Gao J; Gao J; Wang K
Oncotarget; 2016 Nov; 7(48):78619-78630. PubMed ID: 27732935
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of microRNA-9 reduces inflammatory response and fibroblast proliferation in mice with idiopathic pulmonary fibrosis through the ANO1-mediated TGF-β-Smad3 pathway.
Dai WJ; Qiu J; Sun J; Ma CL; Huang N; Jiang Y; Zeng J; Ren BC; Li WC; Li YH
J Cell Physiol; 2019 Mar; 234(3):2552-2565. PubMed ID: 30144053
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ANO1/TMEM16A induces apoptosis in human prostate carcinoma cells by activating TNF-α signaling.
Song Y; Gao J; Guan L; Chen X; Gao J; Wang K
Cell Death Dis; 2018 Jun; 9(6):703. PubMed ID: 29899325
[TBL] [Abstract][Full Text] [Related]
11. Involvement of TMEM16A/ANO1 upregulation in the oncogenesis of colorectal cancer.
Yan Y; Ding X; Han C; Gao J; Liu Z; Liu Y; Wang K
Biochim Biophys Acta Mol Basis Dis; 2022 Jun; 1868(6):166370. PubMed ID: 35231545
[TBL] [Abstract][Full Text] [Related]
12. ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis.
Deng CM; Zhang GG; Liu QW; Xu JJ; Liu ZC; Yang J; Xu TY; Li ZG; Zhang F; Li B
Cancer Res; 2023 Jun; 83(11):1851-1865. PubMed ID: 36912612
[TBL] [Abstract][Full Text] [Related]
13. LXR Signaling-Mediated Cholesterol Metabolism Reprogramming Regulates Cancer Cell Metastasis.
Singh PK; Mehla K
Cancer Res; 2023 Jun; 83(11):1759-1761. PubMed ID: 37264829
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of ANO1 expression in cancers.
Zhang C; Li H; Gao J; Cui X; Yang S; Liu Z
Medicine (Baltimore); 2021 Jan; 100(4):e24525. PubMed ID: 33530281
[TBL] [Abstract][Full Text] [Related]
15. Metabolic reprogramming, autophagy, and ferroptosis: Novel arsenals to overcome immunotherapy resistance in gastrointestinal cancer.
Wang X; Zhou L; Wang H; Chen W; Jiang L; Ming G; Wang J
Cancer Med; 2023 Nov; 12(21):20573-20589. PubMed ID: 37860928
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑144 suppresses aggressive phenotypes of tumor cells by targeting ANO1 in colorectal cancer.
Jiang Y; Cai Y; Shao W; Li F; Guan Z; Zhou Y; Tang C; Feng S
Oncol Rep; 2019 Apr; 41(4):2361-2370. PubMed ID: 30816505
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
[TBL] [Abstract][Full Text] [Related]
18. Targeting inhibition of prognosis-related lipid metabolism genes including CYP19A1 enhances immunotherapeutic response in colon cancer.
Liu L; Mo M; Chen X; Chao D; Zhang Y; Chen X; Wang Y; Zhang N; He N; Yuan X; Chen H; Yang J
J Exp Clin Cancer Res; 2023 Apr; 42(1):85. PubMed ID: 37055842
[TBL] [Abstract][Full Text] [Related]
19. ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancer.
Bill A; Gutierrez A; Kulkarni S; Kemp C; Bonenfant D; Voshol H; Duvvuri U; Gaither LA
Oncotarget; 2015 Apr; 6(11):9173-88. PubMed ID: 25823819
[TBL] [Abstract][Full Text] [Related]
20. Suppression of 14-3-3γ-mediated surface expression of ANO1 inhibits cancer progression of glioblastoma cells.
Lee YS; Lee JK; Bae Y; Lee BS; Kim E; Cho CH; Ryoo K; Yoo J; Kim CH; Yi GS; Lee SG; Lee CJ; Kang SS; Hwang EM; Park JY
Sci Rep; 2016 May; 6():26413. PubMed ID: 27212225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
